Understanding why Black and Hispanic Hodgkin lymphoma patients have worse survival
Official title: Determining Barriers Leading to Inferior Survival for Black and Hispanic Patients with Hodgkin Lymphoma: A Patient-Centered Study
Funded at University of Miami School of Medicine · NIH-11572148 · Data updated 2026-11-12
A patient-centered study to uncover social and care factors that contribute to lower survival among Black and Hispanic people with Hodgkin lymphoma across all ages.
Quick facts
| Grant type | R37 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Miami School of Medicine NIH-funded |
| Lab location | 1 site (Coral Gables, United States) |
| Project start | February 1, 2025 |
| Project end | August 31, 2030 |
| Funding year | 2026 |
| Award (this year) | $350,778 |
| NIH project number | 5R37CA288560-03 |
| Project ID | NIH-11572148 on NIH RePORTER |
Who could benefit from this research
✓Could help
Adults and youths with Hodgkin lymphoma, especially Black or Hispanic individuals, and those navigating survivorship care.
✕Less likely to help
Patients without access to the involved databases or without Black or Hispanic background may see limited direct benefit.
What this research studies
This project will link patient electronic records and transplant data to identify social and care factors that explain why Black and Hispanic patients with Hodgkin lymphoma have poorer survival. Researchers will analyze education, income, insurance, residence, and survivorship care across age groups to find patterns that influence treatment and outcomes. The aim is to build an evidence-based framework that can guide interventions to improve survival for all HL patients, from childhood through older adulthood. The study uses real-world data from large databases to uncover actionable insights for clinicians, patients, and health systems.
Why it matters
Potential benefit: If successful, it could lead to targeted interventions and policies that reduce survival gaps for Black and Hispanic HL patients.
How similar studies have gone: Previous work shows social factors can influence cancer outcomes, but this project seeks to link multiple comprehensive data sources to explain HL-specific survival gaps.
Where this research is happening
-
University of Miami School of Medicine
Coral Gables, United States Active
Researchers
- Principal investigator: Mailhot, Raymond B — University of Miami School of Medicine
- Study coordinator: Mailhot, Raymond B
Related research
Other NIH-funded projects on the same topics.
-
Novel combination therapy for non-Hodgkin lymphoma in people and dogs
A new treatment combo using an oncolytic virus and other therapies is being tested to help people with hard-to-treat non-Hodgkin lymphoma, with studies also involving dogs to better understand responses.
-
Trajectories of Neurotoxicity in young Hodgkin lymphoma patients
Aging Hodgkin lymphoma patients who are adolescents or young adults may face long-lasting brain and nerve-related side effects from their cancer treatment, and this study aims to map how those problems develop over time.
-
Combination therapy approach for non-Hodgkin lymphoma (NHL)
A Mayo Clinic team is testing a new combination treatment for non-Hodgkin lymphoma to improve responses in patients and in dogs with similar disease.
-
Multi-antigen T cell therapy for relapsed NHL
A patient-derived T cell therapy called MT-601 targets six tumor-associated antigens to help treat relapsed non-Hodgkin lymphoma after other therapies may have failed.
-
Personalized de‑intensification of therapy for NLP Hodgkin lymphoma
A clinician-scientist at Stanford is developing a patient-centered program to tailor and reduce therapy for nodular lymphocyte-predominant Hodgkin lymphoma using tumor and blood samples.
-
Combining international Hodgkin lymphoma data to understand long-term treatment effects
This project brings together trial and registry data to learn how treatments affect long-term health in adults with Hodgkin lymphoma.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.